

Source: DGNews | Posted 9 years ago
ELOXATIN, Chemotherapy for Advanced Colorectal Cancer, Receives Approval from the U.S. Food and Drug Administration
Tags:
ELOXATIN Provides a New Treatment for Patients with Advanced Colorectal Cancer
PARIS, FRANCE -- August 12, 2002 -- Sanofi-Synthelabo (Euronext: "SAN" / NYSE: SNY) today announced that ELOXATIN



Comments